Zomedica Corporation (ZOM): Total Debt to Equity Ratio

Market dynamics on GURU.Markets reflect the total debt-to-equity ratio of Zomedica Corp. (ZOM), which stands at 0.00. The business maintains stability through its patented TRUFORMA platforms and investments in R&D. Zomedica Corp. (ZOM) generates revenue from the sale of rapid testing systems and ancillary components for veterinary medicine. High margins are achieved through exclusive cartridges, which make it extremely difficult for clinics to switch to alternative equipment.

Zomedica Corp. (ZOM): Total Debt to Capital Coefficient from 07/04/2022 to 03/15/2025

Metric breakdowns and analytics for Zomedica (ZOM)

- share price and consensus valuation forecast:

Stock Price Zomedica Corp|ZOM - Average Forecast Price

- stock exchange capitalization data:

Market Valuation Zomedica|ZOM - Aggregate Business Value

- book capitalization information:

Net Assets per Single Share Zomedica|ZOM - Book Valuation of Business|Market Cap to Net Assets Ratio zomedica.com|ZOM - Total Asset Value of Company

- debt burden and liquidity indicators:

- net income and valuation ratios data:

ZOM - Net Financial Result

Comprehensive company analysis:Zomedica Corp., ZOM

The total debt-to-equity ratio measures the proportion of borrowed funds relative to equity, determining the degree of financial leverage and the risk of dependence on creditors. By analyzing the historical changes in the total debt-to-equity ratio, an investor can assess how effectively Zomedica Corp. (ZOM) is financing the deployment of the Inertia platform to generate long-term revenue streams from the sale of disposable cartridges.

Competitors of Zomedica Corp.